DE202005007603U1 - Composition for oral or topical administration, e.g. as a dietary supplement or dietetic food, shower gel, body lotion, cream or care concentrate, comprises argan oil and nigella oil - Google Patents
Composition for oral or topical administration, e.g. as a dietary supplement or dietetic food, shower gel, body lotion, cream or care concentrate, comprises argan oil and nigella oil Download PDFInfo
- Publication number
- DE202005007603U1 DE202005007603U1 DE200520007603 DE202005007603U DE202005007603U1 DE 202005007603 U1 DE202005007603 U1 DE 202005007603U1 DE 200520007603 DE200520007603 DE 200520007603 DE 202005007603 U DE202005007603 U DE 202005007603U DE 202005007603 U1 DE202005007603 U1 DE 202005007603U1
- Authority
- DE
- Germany
- Prior art keywords
- oil
- composition according
- sodium
- perfume
- linalool
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003921 oil Substances 0.000 title claims abstract description 48
- 239000000203 mixture Substances 0.000 title claims abstract description 45
- 235000016698 Nigella sativa Nutrition 0.000 title claims abstract description 37
- 239000010478 argan oil Substances 0.000 title claims abstract description 32
- 238000011200 topical administration Methods 0.000 title claims abstract description 4
- 239000012141 concentrate Substances 0.000 title claims description 8
- 239000006071 cream Substances 0.000 title claims description 8
- 235000015872 dietary supplement Nutrition 0.000 title claims description 8
- 235000005911 diet Nutrition 0.000 title claims description 7
- 230000000378 dietary effect Effects 0.000 title claims description 7
- 239000006210 lotion Substances 0.000 title claims description 7
- 235000013305 food Nutrition 0.000 title claims description 6
- 240000008338 Nigella arvensis Species 0.000 title abstract 2
- 235000007413 Nigella arvensis Nutrition 0.000 title abstract 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 57
- 235000019198 oils Nutrition 0.000 claims description 46
- -1 flavorings Substances 0.000 claims description 42
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 claims description 40
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 claims description 40
- 244000090896 Nigella sativa Species 0.000 claims description 35
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 30
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 claims description 30
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 27
- 239000004365 Protease Substances 0.000 claims description 26
- GUUHFMWKWLOQMM-NTCAYCPXSA-N alpha-hexylcinnamaldehyde Chemical compound CCCCCC\C(C=O)=C/C1=CC=CC=C1 GUUHFMWKWLOQMM-NTCAYCPXSA-N 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- GUUHFMWKWLOQMM-UHFFFAOYSA-N alpha-n-hexylcinnamic aldehyde Natural products CCCCCCC(C=O)=CC1=CC=CC=C1 GUUHFMWKWLOQMM-UHFFFAOYSA-N 0.000 claims description 22
- 239000002304 perfume Substances 0.000 claims description 22
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 claims description 20
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 claims description 20
- 102000004190 Enzymes Human genes 0.000 claims description 20
- 108090000790 Enzymes Proteins 0.000 claims description 20
- 229940088598 enzyme Drugs 0.000 claims description 20
- 235000001510 limonene Nutrition 0.000 claims description 20
- 229940087305 limonene Drugs 0.000 claims description 20
- 229930007744 linalool Natural products 0.000 claims description 20
- 229940088594 vitamin Drugs 0.000 claims description 20
- 229930003231 vitamin Natural products 0.000 claims description 20
- 235000013343 vitamin Nutrition 0.000 claims description 20
- 239000011782 vitamin Substances 0.000 claims description 20
- 229920001223 polyethylene glycol Polymers 0.000 claims description 19
- ZCTQGTTXIYCGGC-UHFFFAOYSA-N Benzyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 ZCTQGTTXIYCGGC-UHFFFAOYSA-N 0.000 claims description 18
- 108010019160 Pancreatin Proteins 0.000 claims description 18
- 229940055695 pancreatin Drugs 0.000 claims description 18
- 229930003799 tocopherol Natural products 0.000 claims description 18
- 239000011732 tocopherol Substances 0.000 claims description 18
- 239000000126 substance Substances 0.000 claims description 17
- 239000004367 Lipase Substances 0.000 claims description 16
- 102000004882 Lipase Human genes 0.000 claims description 16
- 108090001060 Lipase Proteins 0.000 claims description 16
- 108091005804 Peptidases Proteins 0.000 claims description 16
- 235000019421 lipase Nutrition 0.000 claims description 16
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 claims description 15
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 claims description 15
- 235000000484 citronellol Nutrition 0.000 claims description 15
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 14
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 14
- 239000004359 castor oil Substances 0.000 claims description 14
- 235000019438 castor oil Nutrition 0.000 claims description 14
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 14
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 14
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 13
- 235000020944 retinol Nutrition 0.000 claims description 13
- 239000011607 retinol Substances 0.000 claims description 13
- 229960003471 retinol Drugs 0.000 claims description 13
- 235000010384 tocopherol Nutrition 0.000 claims description 13
- 229960001295 tocopherol Drugs 0.000 claims description 13
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 12
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 12
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 12
- 229940008099 dimethicone Drugs 0.000 claims description 12
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 12
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 12
- 239000000787 lecithin Substances 0.000 claims description 12
- 229940067606 lecithin Drugs 0.000 claims description 12
- 235000010445 lecithin Nutrition 0.000 claims description 12
- 229960005323 phenoxyethanol Drugs 0.000 claims description 12
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 12
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 11
- 239000003963 antioxidant agent Substances 0.000 claims description 11
- 235000006708 antioxidants Nutrition 0.000 claims description 11
- 108090000270 Ficain Proteins 0.000 claims description 10
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 10
- POTUGHMKJGOKRI-UHFFFAOYSA-N ficin Chemical compound FI=CI=N POTUGHMKJGOKRI-UHFFFAOYSA-N 0.000 claims description 10
- 235000019836 ficin Nutrition 0.000 claims description 10
- 229940119170 jojoba wax Drugs 0.000 claims description 10
- 235000010234 sodium benzoate Nutrition 0.000 claims description 10
- 239000004299 sodium benzoate Substances 0.000 claims description 10
- ORMHZBNNECIKOH-UHFFFAOYSA-N 4-(4-hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde Chemical compound CC(C)(O)CCCC1=CCC(C=O)CC1 ORMHZBNNECIKOH-UHFFFAOYSA-N 0.000 claims description 9
- 244000144725 Amygdalus communis Species 0.000 claims description 9
- 235000011437 Amygdalus communis Nutrition 0.000 claims description 9
- 244000125300 Argania sideroxylon Species 0.000 claims description 9
- 235000016108 Argania sideroxylon Nutrition 0.000 claims description 9
- 239000000499 gel Substances 0.000 claims description 9
- 239000001711 nigella sativa Substances 0.000 claims description 9
- 230000000699 topical effect Effects 0.000 claims description 9
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 claims description 8
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 8
- 235000019419 proteases Nutrition 0.000 claims description 8
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 8
- 108010013296 Sericins Proteins 0.000 claims description 7
- 239000008168 almond oil Substances 0.000 claims description 7
- 239000004202 carbamide Substances 0.000 claims description 7
- 239000007765 cera alba Substances 0.000 claims description 7
- 235000008390 olive oil Nutrition 0.000 claims description 7
- 239000004006 olive oil Substances 0.000 claims description 7
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 7
- 239000011780 sodium chloride Substances 0.000 claims description 7
- CRPCXAMJWCDHFM-UHFFFAOYSA-M sodium;5-oxopyrrolidine-2-carboxylate Chemical compound [Na+].[O-]C(=O)C1CCC(=O)N1 CRPCXAMJWCDHFM-UHFFFAOYSA-M 0.000 claims description 7
- DHVLDKHFGIVEIP-UHFFFAOYSA-N 2-bromo-2-(bromomethyl)pentanedinitrile Chemical compound BrCC(Br)(C#N)CCC#N DHVLDKHFGIVEIP-UHFFFAOYSA-N 0.000 claims description 6
- 239000005715 Fructose Substances 0.000 claims description 6
- 229930091371 Fructose Natural products 0.000 claims description 6
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 6
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 claims description 6
- PXTQQOLKZBLYDY-UHFFFAOYSA-N bis(2-ethylhexyl) carbonate Chemical compound CCCCC(CC)COC(=O)OCC(CC)CCCC PXTQQOLKZBLYDY-UHFFFAOYSA-N 0.000 claims description 6
- SDQFDHOLCGWZPU-UHFFFAOYSA-N lilial Chemical compound O=CC(C)CC1=CC=C(C(C)(C)C)C=C1 SDQFDHOLCGWZPU-UHFFFAOYSA-N 0.000 claims description 6
- 229940094944 saccharide isomerate Drugs 0.000 claims description 6
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 5
- DWHIUNMOTRUVPG-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCO DWHIUNMOTRUVPG-UHFFFAOYSA-N 0.000 claims description 5
- 235000002961 Aloe barbadensis Nutrition 0.000 claims description 5
- 244000144927 Aloe barbadensis Species 0.000 claims description 5
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 claims description 5
- 239000004471 Glycine Substances 0.000 claims description 5
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 5
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 5
- 240000007817 Olea europaea Species 0.000 claims description 5
- 235000002725 Olea europaea Nutrition 0.000 claims description 5
- 239000002202 Polyethylene glycol Substances 0.000 claims description 5
- 235000011399 aloe vera Nutrition 0.000 claims description 5
- 235000021466 carotenoid Nutrition 0.000 claims description 5
- 150000001747 carotenoids Chemical class 0.000 claims description 5
- 229940106189 ceramide Drugs 0.000 claims description 5
- 229940043350 citral Drugs 0.000 claims description 5
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 5
- 239000000194 fatty acid Substances 0.000 claims description 5
- 229930195729 fatty acid Natural products 0.000 claims description 5
- 150000004665 fatty acids Chemical class 0.000 claims description 5
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 claims description 5
- 235000011187 glycerol Nutrition 0.000 claims description 5
- 229940075529 glyceryl stearate Drugs 0.000 claims description 5
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 5
- 229960000367 inositol Drugs 0.000 claims description 5
- 229940031674 laureth-7 Drugs 0.000 claims description 5
- 229960003966 nicotinamide Drugs 0.000 claims description 5
- 235000005152 nicotinamide Nutrition 0.000 claims description 5
- 239000011570 nicotinamide Substances 0.000 claims description 5
- 229920002401 polyacrylamide Polymers 0.000 claims description 5
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 5
- 235000019149 tocopherols Nutrition 0.000 claims description 5
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 claims description 5
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 claims description 4
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 4
- ALQSHHUCVQOPAS-UHFFFAOYSA-N Pentane-1,5-diol Chemical compound OCCCCCO ALQSHHUCVQOPAS-UHFFFAOYSA-N 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- 235000004433 Simmondsia californica Nutrition 0.000 claims description 4
- 244000044822 Simmondsia californica Species 0.000 claims description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 4
- 239000000969 carrier Substances 0.000 claims description 4
- 150000001783 ceramides Chemical class 0.000 claims description 4
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 claims description 4
- 125000005456 glyceride group Chemical group 0.000 claims description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 4
- 239000001540 sodium lactate Substances 0.000 claims description 4
- 229940005581 sodium lactate Drugs 0.000 claims description 4
- 235000011088 sodium lactate Nutrition 0.000 claims description 4
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims description 4
- 229910052721 tungsten Inorganic materials 0.000 claims description 4
- 235000019156 vitamin B Nutrition 0.000 claims description 4
- 239000011720 vitamin B Substances 0.000 claims description 4
- 239000011701 zinc Substances 0.000 claims description 4
- 229910052725 zinc Inorganic materials 0.000 claims description 4
- 235000016804 zinc Nutrition 0.000 claims description 4
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 claims description 3
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 claims description 3
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 claims description 3
- IXOCGRPBILEGOX-UHFFFAOYSA-N 3-[3-(dodecanoylamino)propyl-dimethylazaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(O)CS([O-])(=O)=O IXOCGRPBILEGOX-UHFFFAOYSA-N 0.000 claims description 3
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 claims description 3
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 claims description 3
- 239000004698 Polyethylene Substances 0.000 claims description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 3
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- JZGWEIPJUAIDHM-UHFFFAOYSA-N chembl2007771 Chemical compound C1=CC=C2C(N=NC3=C4C(=CC(=CC4=CC=C3O)S(O)(=O)=O)S(O)(=O)=O)=CC=C(S(O)(=O)=O)C2=C1 JZGWEIPJUAIDHM-UHFFFAOYSA-N 0.000 claims description 3
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 claims description 3
- 229940073507 cocamidopropyl betaine Drugs 0.000 claims description 3
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims description 3
- 239000000975 dye Substances 0.000 claims description 3
- 239000007903 gelatin capsule Substances 0.000 claims description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 3
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 3
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 claims description 3
- 239000011707 mineral Substances 0.000 claims description 3
- 235000010755 mineral Nutrition 0.000 claims description 3
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 3
- 239000012188 paraffin wax Substances 0.000 claims description 3
- 229920000573 polyethylene Polymers 0.000 claims description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 3
- 235000013824 polyphenols Nutrition 0.000 claims description 3
- 235000012731 ponceau 4R Nutrition 0.000 claims description 3
- 229960004063 propylene glycol Drugs 0.000 claims description 3
- 229940108325 retinyl palmitate Drugs 0.000 claims description 3
- 235000019172 retinyl palmitate Nutrition 0.000 claims description 3
- 239000011769 retinyl palmitate Substances 0.000 claims description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 3
- 235000012756 tartrazine Nutrition 0.000 claims description 3
- 239000004149 tartrazine Substances 0.000 claims description 3
- 235000013619 trace mineral Nutrition 0.000 claims description 3
- 239000011573 trace mineral Substances 0.000 claims description 3
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 claims description 3
- WSGCRSMLXFHGRM-DEVHWETNSA-N (2s)-2-[[(2s)-6-amino-2-[[(2s,3r)-2-[[(2s,3r)-2-[[(2s)-6-amino-2-(hexadecanoylamino)hexanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxybutanoyl]amino]hexanoyl]amino]-3-hydroxypropanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O WSGCRSMLXFHGRM-DEVHWETNSA-N 0.000 claims description 2
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 claims description 2
- KVZLHPXEUGJPAH-UHFFFAOYSA-N 2-oxidanylpropanoic acid Chemical compound CC(O)C(O)=O.CC(O)C(O)=O KVZLHPXEUGJPAH-UHFFFAOYSA-N 0.000 claims description 2
- MBVFRSJFKMJRHA-UHFFFAOYSA-N 4-fluoro-1-benzofuran-7-carbaldehyde Chemical compound FC1=CC=C(C=O)C2=C1C=CO2 MBVFRSJFKMJRHA-UHFFFAOYSA-N 0.000 claims description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 2
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims description 2
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 claims description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 2
- 235000019487 Hazelnut oil Nutrition 0.000 claims description 2
- 240000000950 Hippophae rhamnoides Species 0.000 claims description 2
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims description 2
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims description 2
- 239000004909 Moisturizer Substances 0.000 claims description 2
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 claims description 2
- ATGQXSBKTQANOH-UWVGARPKSA-N N-oleoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC ATGQXSBKTQANOH-UWVGARPKSA-N 0.000 claims description 2
- 235000019482 Palm oil Nutrition 0.000 claims description 2
- 235000019483 Peanut oil Nutrition 0.000 claims description 2
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 2
- 235000019484 Rapeseed oil Nutrition 0.000 claims description 2
- 235000019485 Safflower oil Nutrition 0.000 claims description 2
- 229920002125 Sokalan® Polymers 0.000 claims description 2
- 235000019486 Sunflower oil Nutrition 0.000 claims description 2
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 claims description 2
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 claims description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 2
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 claims description 2
- 229940061720 alpha hydroxy acid Drugs 0.000 claims description 2
- 150000001280 alpha hydroxy acids Chemical class 0.000 claims description 2
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 2
- 239000002518 antifoaming agent Substances 0.000 claims description 2
- 239000002216 antistatic agent Substances 0.000 claims description 2
- 239000008365 aqueous carrier Substances 0.000 claims description 2
- 235000013793 astaxanthin Nutrition 0.000 claims description 2
- 239000001168 astaxanthin Substances 0.000 claims description 2
- 229940022405 astaxanthin Drugs 0.000 claims description 2
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims description 2
- 235000021302 avocado oil Nutrition 0.000 claims description 2
- 239000008163 avocado oil Substances 0.000 claims description 2
- 235000013734 beta-carotene Nutrition 0.000 claims description 2
- 239000011648 beta-carotene Substances 0.000 claims description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 2
- 229960002747 betacarotene Drugs 0.000 claims description 2
- 239000000872 buffer Substances 0.000 claims description 2
- 239000010495 camellia oil Substances 0.000 claims description 2
- 150000001720 carbohydrates Chemical class 0.000 claims description 2
- 229960001631 carbomer Drugs 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 235000019864 coconut oil Nutrition 0.000 claims description 2
- 239000003240 coconut oil Substances 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 229910052802 copper Inorganic materials 0.000 claims description 2
- 239000010949 copper Substances 0.000 claims description 2
- 235000005687 corn oil Nutrition 0.000 claims description 2
- 239000002285 corn oil Substances 0.000 claims description 2
- 235000012343 cottonseed oil Nutrition 0.000 claims description 2
- 239000002385 cottonseed oil Substances 0.000 claims description 2
- 235000001671 coumarin Nutrition 0.000 claims description 2
- 229960000956 coumarin Drugs 0.000 claims description 2
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims description 2
- 239000003599 detergent Substances 0.000 claims description 2
- 239000003995 emulsifying agent Substances 0.000 claims description 2
- 235000008524 evening primrose extract Nutrition 0.000 claims description 2
- 239000010475 evening primrose oil Substances 0.000 claims description 2
- 229940089020 evening primrose oil Drugs 0.000 claims description 2
- 235000021323 fish oil Nutrition 0.000 claims description 2
- 239000004872 foam stabilizing agent Substances 0.000 claims description 2
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 claims description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 claims description 2
- 239000008169 grapeseed oil Substances 0.000 claims description 2
- 239000010468 hazelnut oil Substances 0.000 claims description 2
- IIRDTKBZINWQAW-UHFFFAOYSA-N hexaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCO IIRDTKBZINWQAW-UHFFFAOYSA-N 0.000 claims description 2
- UQEAIHBTYFGYIE-UHFFFAOYSA-N hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 claims description 2
- 239000003906 humectant Substances 0.000 claims description 2
- 239000004310 lactic acid Substances 0.000 claims description 2
- 235000014655 lactic acid Nutrition 0.000 claims description 2
- 235000021388 linseed oil Nutrition 0.000 claims description 2
- 239000000944 linseed oil Substances 0.000 claims description 2
- 235000012680 lutein Nutrition 0.000 claims description 2
- 239000001656 lutein Substances 0.000 claims description 2
- 229960005375 lutein Drugs 0.000 claims description 2
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims description 2
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims description 2
- 235000012661 lycopene Nutrition 0.000 claims description 2
- 239000001751 lycopene Substances 0.000 claims description 2
- 229960004999 lycopene Drugs 0.000 claims description 2
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 2
- 229910044991 metal oxide Inorganic materials 0.000 claims description 2
- 150000004706 metal oxides Chemical class 0.000 claims description 2
- 239000002480 mineral oil Substances 0.000 claims description 2
- 230000001333 moisturizer Effects 0.000 claims description 2
- 229910052750 molybdenum Inorganic materials 0.000 claims description 2
- 239000011733 molybdenum Substances 0.000 claims description 2
- 235000016768 molybdenum Nutrition 0.000 claims description 2
- 230000007935 neutral effect Effects 0.000 claims description 2
- 235000019488 nut oil Nutrition 0.000 claims description 2
- 239000010466 nut oil Substances 0.000 claims description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 2
- 229960002446 octanoic acid Drugs 0.000 claims description 2
- 150000007524 organic acids Chemical class 0.000 claims description 2
- 235000005985 organic acids Nutrition 0.000 claims description 2
- 239000003346 palm kernel oil Substances 0.000 claims description 2
- 235000019865 palm kernel oil Nutrition 0.000 claims description 2
- 239000002540 palm oil Substances 0.000 claims description 2
- 239000000312 peanut oil Substances 0.000 claims description 2
- 239000004014 plasticizer Substances 0.000 claims description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 2
- 229940068977 polysorbate 20 Drugs 0.000 claims description 2
- 239000003755 preservative agent Substances 0.000 claims description 2
- CMDGQTVYVAKDNA-UHFFFAOYSA-N propane-1,2,3-triol;hydrate Chemical compound O.OCC(O)CO CMDGQTVYVAKDNA-UHFFFAOYSA-N 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 239000001944 prunus armeniaca kernel oil Substances 0.000 claims description 2
- 239000008171 pumpkin seed oil Substances 0.000 claims description 2
- 235000005713 safflower oil Nutrition 0.000 claims description 2
- 239000003813 safflower oil Substances 0.000 claims description 2
- 235000011803 sesame oil Nutrition 0.000 claims description 2
- 239000008159 sesame oil Substances 0.000 claims description 2
- 239000000377 silicon dioxide Substances 0.000 claims description 2
- 229940057950 sodium laureth sulfate Drugs 0.000 claims description 2
- 229940045635 sodium pyroglutamate Drugs 0.000 claims description 2
- CRPCXAMJWCDHFM-DFWYDOINSA-M sodium;(2s)-5-oxopyrrolidine-2-carboxylate Chemical compound [Na+].[O-]C(=O)[C@@H]1CCC(=O)N1 CRPCXAMJWCDHFM-DFWYDOINSA-M 0.000 claims description 2
- SXHLENDCVBIJFO-UHFFFAOYSA-M sodium;2-[2-(2-dodecoxyethoxy)ethoxy]ethyl sulfate Chemical compound [Na+].CCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O SXHLENDCVBIJFO-UHFFFAOYSA-M 0.000 claims description 2
- 235000012424 soybean oil Nutrition 0.000 claims description 2
- 239000003549 soybean oil Substances 0.000 claims description 2
- 150000005846 sugar alcohols Chemical class 0.000 claims description 2
- 230000037072 sun protection Effects 0.000 claims description 2
- 239000002600 sunflower oil Substances 0.000 claims description 2
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 claims description 2
- 239000002562 thickening agent Substances 0.000 claims description 2
- 229940042585 tocopherol acetate Drugs 0.000 claims description 2
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims description 2
- 229940099259 vaseline Drugs 0.000 claims description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 2
- 239000001993 wax Substances 0.000 claims description 2
- 239000010497 wheat germ oil Substances 0.000 claims description 2
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims description 2
- 235000010930 zeaxanthin Nutrition 0.000 claims description 2
- 239000001775 zeaxanthin Substances 0.000 claims description 2
- 229940043269 zeaxanthin Drugs 0.000 claims description 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 2
- 150000007513 acids Chemical class 0.000 claims 1
- 239000003086 colorant Substances 0.000 claims 1
- 239000000796 flavoring agent Substances 0.000 claims 1
- 235000013355 food flavoring agent Nutrition 0.000 claims 1
- 239000003205 fragrance Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 13
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 4
- 229960003444 immunosuppressant agent Drugs 0.000 abstract 1
- 230000001861 immunosuppressant effect Effects 0.000 abstract 1
- 239000003018 immunosuppressive agent Substances 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 17
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 13
- 235000015165 citric acid Nutrition 0.000 description 12
- 229960004106 citric acid Drugs 0.000 description 12
- GMVPRGQOIOIIMI-UHFFFAOYSA-N (8R,11R,12R,13E,15S)-11,15-Dihydroxy-9-oxo-13-prostenoic acid Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CCCCCCC(O)=O GMVPRGQOIOIIMI-UHFFFAOYSA-N 0.000 description 9
- 108060005980 Collagenase Proteins 0.000 description 9
- 229960000711 alprostadil Drugs 0.000 description 9
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 9
- GMVPRGQOIOIIMI-DWKJAMRDSA-N prostaglandin E1 Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O GMVPRGQOIOIIMI-DWKJAMRDSA-N 0.000 description 9
- 102000008186 Collagen Human genes 0.000 description 8
- 102000029816 Collagenase Human genes 0.000 description 8
- 102000035195 Peptidases Human genes 0.000 description 8
- 235000021342 arachidonic acid Nutrition 0.000 description 8
- 229940114079 arachidonic acid Drugs 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 229920001436 collagen Polymers 0.000 description 8
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 8
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 8
- 229960002733 gamolenic acid Drugs 0.000 description 8
- 108010035532 Collagen Proteins 0.000 description 7
- 208000010668 atopic eczema Diseases 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 230000000172 allergic effect Effects 0.000 description 6
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 5
- 230000008929 regeneration Effects 0.000 description 5
- 238000011069 regeneration method Methods 0.000 description 5
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 5
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 5
- 210000000170 cell membrane Anatomy 0.000 description 4
- 229960002986 dinoprostone Drugs 0.000 description 4
- 229960002737 fructose Drugs 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 210000003491 skin Anatomy 0.000 description 4
- HOBAELRKJCKHQD-UHFFFAOYSA-N (8Z,11Z,14Z)-8,11,14-eicosatrienoic acid Natural products CCCCCC=CCC=CCC=CCCCCCCC(O)=O HOBAELRKJCKHQD-UHFFFAOYSA-N 0.000 description 3
- 102100034544 Acyl-CoA 6-desaturase Human genes 0.000 description 3
- 235000021298 Dihomo-γ-linolenic acid Nutrition 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 3
- 108010037138 Linoleoyl-CoA Desaturase Proteins 0.000 description 3
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 3
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- HOBAELRKJCKHQD-QNEBEIHSSA-N dihomo-γ-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HOBAELRKJCKHQD-QNEBEIHSSA-N 0.000 description 3
- 229960002449 glycine Drugs 0.000 description 3
- 230000004957 immunoregulator effect Effects 0.000 description 3
- 235000020778 linoleic acid Nutrition 0.000 description 3
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 3
- 229960004488 linolenic acid Drugs 0.000 description 3
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 3
- 229960003885 sodium benzoate Drugs 0.000 description 3
- 229940045136 urea Drugs 0.000 description 3
- IMAYJYGCQCZYID-UHFFFAOYSA-N 1,3,5,7,9,11-hexaoxa-2,4,6,8,10,12-hexasilacyclododecane Chemical class O1[SiH2]O[SiH2]O[SiH2]O[SiH2]O[SiH2]O[SiH2]1 IMAYJYGCQCZYID-UHFFFAOYSA-N 0.000 description 2
- CCPYCNSBZPTUMJ-UHFFFAOYSA-N 1,3,5,7,9,2,4,6,8,10-pentaoxapentasilecane Chemical class O1[SiH2]O[SiH2]O[SiH2]O[SiH2]O[SiH2]1 CCPYCNSBZPTUMJ-UHFFFAOYSA-N 0.000 description 2
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical class OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 210000003719 b-lymphocyte Anatomy 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000000855 fungicidal effect Effects 0.000 description 2
- 210000003630 histaminocyte Anatomy 0.000 description 2
- 230000028996 humoral immune response Effects 0.000 description 2
- 230000003716 rejuvenation Effects 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- HNXRLRRQDUXQEE-ALURDMBKSA-N (2s,3r,4s,5r,6r)-2-[[(2r,3s,4r)-4-hydroxy-2-(hydroxymethyl)-3,4-dihydro-2h-pyran-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC=C[C@H]1O HNXRLRRQDUXQEE-ALURDMBKSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 208000035484 Cellulite Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 201000009053 Neurodermatitis Diseases 0.000 description 1
- 206010049752 Peau d'orange Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- YSKVBPGQYRAUQO-UZSYLJJSSA-N Schottenol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)CC[C@@H](CC)C(C)C)CC[C@H]33)C)C3=CC[C@H]21 YSKVBPGQYRAUQO-UZSYLJJSSA-N 0.000 description 1
- YSKVBPGQYRAUQO-UHFFFAOYSA-N Schottenol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CCC21 YSKVBPGQYRAUQO-UHFFFAOYSA-N 0.000 description 1
- 239000004141 Sodium laurylsulphate Substances 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000003679 aging effect Effects 0.000 description 1
- 201000009961 allergic asthma Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- JZVFJDZBLUFKCA-FXIAWGAOSA-N alpha-Spinasterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)CC[C@H]33)C)C3=CC[C@H]21 JZVFJDZBLUFKCA-FXIAWGAOSA-N 0.000 description 1
- JZVFJDZBLUFKCA-UTQQLQBSSA-N alpha-spinasterol Natural products CC[C@H](C=C[C@H](C)[C@H]1CC[C@H]2C3=CC[C@@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C JZVFJDZBLUFKCA-UTQQLQBSSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000001028 anti-proliverative effect Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- DCFDVJPDXYGCOK-UHFFFAOYSA-N cyclohex-3-ene-1-carbaldehyde Chemical compound O=CC1CCC=CC1 DCFDVJPDXYGCOK-UHFFFAOYSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000000834 fixative Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 230000009422 growth inhibiting effect Effects 0.000 description 1
- 239000000118 hair dye Substances 0.000 description 1
- 239000008266 hair spray Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000000887 hydrating effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229940060184 oil ingredients Drugs 0.000 description 1
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 1
- 229940033080 omega-6 fatty acid Drugs 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000003075 phytoestrogen Substances 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000019719 rose oil Nutrition 0.000 description 1
- 239000010666 rose oil Substances 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- 235000012045 salad Nutrition 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- GHIZCSMTYWOBQA-BZSCQJQFSA-N spinasterol Natural products CC[C@H](C=C[C@@H](C)[C@@H]1CC[C@@]2(C)C3=CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C)C(C)C GHIZCSMTYWOBQA-BZSCQJQFSA-N 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000010496 thistle oil Substances 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Abstract
Description
Die vorliegende Erfindung betrifft eine Zusammensetzung zur oralen oder topischen Verabreichung umfassend eine Kombination aus Arganöl und Schwarzkümmelöl.The The present invention relates to a composition for oral or topical administration comprising a combination of argan oil and black cumin oil.
Arganöl wird aus den pflaumen- oder olivenartigen Früchten des Baumes Argania spinosa gewonnen, eines der ältesten Bäume der Welt welcher nur noch im südwestlichen Marokko zwischen Essaoira und Agadir vorkommt.Argan oil is going out the plum or olive-like fruits of the tree Argania spinosa won, one of the oldest Trees the World which only in the southwestern Morocco occurs between Essaoira and Agadir.
Arganöl gilt als medizinisch besonders wertvoll, da es unter anderem über 80% ungesättigte Fettsäuren, Antioxidantien (u.a. Tocopherol), fungizide and bakterizide Querzitine und Myrizetine sowie die Sterine Schottenol und Spinasterol enthält.Argan oil is considered medically particularly valuable, as it contains more than 80% unsaturated fatty acids, Antioxidants (including tocopherol), fungicidal and bactericidal cross-cites and myrtitines, as well as the sterols containing schottenol and spinasterol.
Arganöl wird bisher unter anderem zum Kochen und für Salate sowie in der Naturmedizin zur Behandlung von Sonnenbrand, Neurodermitis und Psoriasis, zur Desinfektion und Heilungsförderung von Wunden, zur Senkung des Cholesterinspiegels sowie zur Vorbeugung von Arteriosklerose und Linderung von Rheumatischen Erkrankungen verwendet.Argan oil is so far including for cooking and for Salads and in natural medicine for the treatment of sunburn, Neurodermatitis and psoriasis, for disinfection and healing of wounds, to lower cholesterol and prevent of arteriosclerosis and relief of rheumatic diseases used.
Zu den dem Arganöl zugeschriebenen allgemeinen günstigen Wirkungen zählen unter anderem die antioxidative Wirkung auf Grund seines hohen Gehaltes an ungesättigten Fettsäuren and an Tocopherol, die desifizierende Wirkung, die feuchtigkeitsspendende (hydratisierende) Wirkung, eine fungizide Wirkung, eine bakterizide Wirkung sowie eine durchblutungsfördernde Wirkung, eine zellverjüngende und abwehrstärkende Wirkung.To the argan oil attributed to general cheap Count effects Among other things, the antioxidant effect due to its high content in unsaturated fatty acids and tocopherol, the desifizierende effect, the moisturizing (hydrating) effect, a fungicidal action, a bactericidal Effect as well as a circulation-promoting effect, a cell-rejuvenating and Defense-enhancing effect.
Schwarzkümmelöl wird aus den Samen der Nigella sativa, einer Pflanze die zu den Hahnenfussgewächsen gehört gewonnen, einer Verwandten der bekannten „Jungfer im Grünen". Es wird seit langem im Orient als traditionelles Heilmittel verwendet. Nachgewiesen werden konnte u.a. eine positive Auswirkung auf den Verlauf von Rheumatischen Erkrankungen und eine wachstumshemmende Wirkung auf Tumorzellen. Zudem soll Schwarzkümmelöl Bakterien und Pilze abtöten. Erfolge wurden auch bei der Behandlung von allergischen Erkrankungen wie Neurodermitis und Asthma erzielt.Black cumin oil gets out the seeds of Nigella sativa, a plant belonging to the buttercup family, a relative of the well-known "virgin in the green." It has been a long time Used in the Orient as a traditional remedy. demonstrated could be u.a. a positive impact on the course of Rheumatic diseases and a growth-inhibiting effect Tumor cells. In addition, black cumin oil is said to be bacteria and kill mushrooms. Successes have also been seen in the treatment of allergic diseases how eczema and asthma are achieved.
Das native kaltgepresste Öl weist unter anderem einen hohen Gehalt an mehrfach ungesättigten Fettsäuren, wie vor allem der Linolensäure auf, aus der im menschlichen Körper durch das Enzym Delta-6-Desaturase die Gamma-Linolensäure und die Arachidonsäure entsteht. Aus der Gamma-Linolensäure, welche die Zellmembranen stabilisiert, entsteht Prostaglandin E1 (PGE1) welches wiederum stark entzündungshemmend ist und die Freisetzung allergischer Mediatoren hemmt. Ferner stabilisiert Schwarzkümmelöl auch die übersteigerte T-Zellfunktion des Allergikers und unterdrückt die pathologisch gesteigerte humorale Immunreaktion der B-Zellen. Zudem entsteht aus der Arachidonsäure Prostaglandin E2 (PGE2) was zusätzlich stark bronchienerweiternd wirkt.The native cold pressed oil has, inter alia, a high content of polyunsaturated fatty acids, especially the linolenic acid on, out of the human body the enzyme delta-6-desaturase produces gamma-linolenic acid and arachidonic acid. From gamma-linolenic acid, which stabilizes the cell membranes, produces prostaglandin E1 (PGE1) which in turn is highly anti-inflammatory and the release allergic mediators inhibits. Furthermore, black cumin oil also stabilizes the exaggerated T-cell function of the allergic and suppresses the pathologically increased humoral immune response of B cells. In addition, the arachidonic acid produces prostaglandin E2 (PGE2) what additional Strong bronchieerweiternd acts.
Aufgabe der vorliegenden Erfindung ist es, eine Zusammensetzung bereitzustellen, welche eine direkte Wirkung auf den Zellregenerationsprozess und damit auf die Zellneubildung hat.task the present invention is to provide a composition which has a direct effect on the cell regeneration process and so on the cell neoformation has.
Erfindungsgemäss wurde nun festgestellt, dass eine Kombination der beiden obengenannten Öle sowohl bei der topischen als auch bei der oralen Applikation zu einer unerwarteten gesteigerten Wirkung auf den Zellregenerationsprozess führt, so dass neben einer erhöhten Zellneubildung auch, oder insbesondere eine Verjüngung bereits vorhandener Zellen beobachtet werden kann.According to the invention was now found that a combination of the above two oils both in the topical as well as in the oral application to an unexpected has an increased effect on the cell regeneration process, so that in addition to an elevated Cell regeneration also, or in particular a rejuvenation of already existing cells can be observed.
Der genaue Mechanismus der dieser erfindungsgemäßen einzigartigen Wirkung der Kombination der beiden Öle zu Grunde liegt, ist bisher unbekannt.Of the exact mechanism of this unique effect of the invention Combination of the two oils underlying is so far unknown.
Es ist jedoch davon auszugehen, dass diese durch die optimale Synergie der verschiedenen antioxidativen, entzündungshemmenden und immunregulatorischen Inhaltsstoffe zustande kommt.It However, it can be assumed that this is due to the optimal synergy of various antioxidant, anti-inflammatory and immunoregulatory Ingredients comes about.
Dieser synergistische Effekt kann wie folgt erklärt werden:This synergistic effect can be explained as follows:
Beim Atopiker ist bekannt, dass die Synthese wichtiger hormonähnlicher, immunregulatorischer Substanzen wie Prostaglandin E1 und E2 (PGE1 und PGE2) aus Gamma-Linolensäure und Arachidonsäure gestört ist bzw. vollständig fehlt, was vermutlich auf einen Enzymdefekt der Delta-6-Desaturase zurückzuführen ist.At the Atopics are known to be involved in the synthesis of important hormone-like, immunoregulatory substances such as prostaglandin E1 and E2 (PGE1 and PGE2) from gamma-linolenic acid and arachidonic acid disturbed is or completely is missing, which is probably due to an enzyme defect of delta-6-desaturase is due.
Die essentiellen ungesättigten Fettsäuren Linolsäure, Gamma-Linolensäure und Arachidonsäure können vom Menschen nicht selber synthetisiert werden, jedoch kann Arachidonsäure aus Linolsäure entstehen. So wird ein Teil der mit der Nahrung aufgenommenen Linolsäure im Körper enzymatisch durch die Delta-6-Desaturase zur Gamma-Linolensäure (GLA), einer dreifach ungesättigten Omega-6-Fettsäure, umgewandelt.The essential unsaturated fatty acids linoleic acid, Gamma-linolenic acid and arachidonic acid can may not be synthesized by humans, however, may be from arachidonic acid linoleic acid arise. Thus, part of the dietary linoleic acid in the body becomes enzymatic by the delta-6 desaturase to gamma-linolenic acid (GLA), a triunsaturated Omega-6 fatty acid, transformed.
In der Haut wird Linolsäure entweder in das barriereaktive Ceramid I eingebaut oder enzymatisch zu einer Fettsäure mit antiproliferativer Wirkung oxidiert. Aus Gamma-Linolensäure wird durch Kettenverlängerung die Dihomo-gamma-Linolensäure (DGL) und nachfolgend die vierfach ungesättigte Arachidonsäure (AA) gebildet. Die Arachidonsäure wird unter anderem in epidermalen Phospholipiden zwischengespeichert. Aus Arachidonsäure entsteht Prostaglandin E2 (PGE2), aus Gamma-Linolensäure entsteht über die Dihomogamma-Linolensäure Prostaglandin E1 (PGE1).In the skin becomes linoleic acid either incorporated into the barrier-active ceramide I or enzymatically to a fatty acid Oxidized with antiproliferative effect. From gamma-linolenic acid is by chain extension Dihomo-gamma-linolenic acid (DGL) and subsequently formed the quadruply unsaturated arachidonic acid (AA). The arachidonic acid is cached inter alia in epidermal phospholipids. From arachidonic acid arises prostaglandin E2 (PGE2), from gamma-linolenic acid arises over the Dihomogamma-linolenic acid Prostaglandin E1 (PGE1).
Folgende immunregulatorischen Effekte der Prostaglandine PGE1 und PGE2 kann man sich, insbesondere beim Atopiker, zu Nutze machen:The following immunoregulatory effects of prostaglandins PGE1 and PGE2 can to make use of oneself, especially at the Atopiker:
Während Gamma-Linolensäure die Zellmembranen stabilisiert, wirkt PGE1 stark entzündungshemmend und hemmt so die Freisetzung von allergischen Mediatoren. Außerdem stabilisiert PGE1 die übersteigerte T-Zellfunktion des Allergikers und unterdrückt die pathologisch gesteigerte humorale Immunreaktion der B-Zellen. Die überschießende IgE-Synthese wird normalisiert und so die Mastzelldegranulation verringert.While gamma-linolenic acid the Stabilized cell membranes, PGE1 has a strong anti-inflammatory and thus inhibits the release of allergic mediators. Also stabilized PGE1 the exaggerated T-cell function of the allergic and suppresses the pathologically increased humoral immune response of B cells. The excess IgE synthesis is normalized and so reduces mast cell degranulation.
PGE2 wirkt zusätzlich bronchienerweiternd, was zum Beispiel beim allergischen Asthma von therapeutischem Nutzen ist.PGE2 acts additionally bronchial dilating, what for example in the allergic asthma of therapeutic benefit.
Die für einen Allergiker notwendige vermehrte Zufuhr von ungesättigten Fettsäuren, insbesondere Gamma-Linolensäure ist mit der normalen Ernährung nicht möglich. Hingegen bessert die längerfristige, konsequente Nahrungsergänzung mit Schwarzkümmelöl, das einen hohen Anteil ungesättigter Fettsäuren vor allem der Linolensäure aufweist, die verschiedenen Symptome des Allergikers in bis zu 90 % der Fälle.The for one Allergic is necessary increased intake of unsaturated fatty acids, especially gamma-linolenic acid with the normal diet not possible. On the other hand, the longer-term, consistent nutritional supplement with black cumin oil, the one high proportion of unsaturated fatty acids especially the linolenic acid exhibits the various symptoms of the allergy in up to 90 % of cases.
So bestätigen wissenschaftliche Untersuchungen, dass die Einnahme von 200 – 500 mg Schwarzkümmelöl, täglich über einen Zeitraum von 3 – 6 Monaten gegeben, ein effektives und sehr gut verträgliches Therapiekonzept für Allergiker darstellt.So to confirm scientific researches that the intake of 200 - 500 mg Black cumin oil, daily over one Period from 3 - 6 Given months, an effective and very well tolerated Therapy concept for Allergic presents.
Erfindungsgemäß hat man nun gefunden, dass durch die Kombination von Schwarzkümmelöl mit Arganöl eine gesteigerte Wirkung der immunologischen Effekte erzielt werden können. Diese potenzierte Wirkung ist insbesondere auf den Gehalt an Antioxidantien, wie Tocopherol, zurückzuführen.According to the invention one has Now found that by combining black cumin oil with argan oil an increased Effect of immunological effects can be achieved. These potentiated effect is particularly due to the content of antioxidants, such as tocopherol.
Durch die erfindungsgemäße Kombination werden folglich einerseits die pathogenen Immunreaktionen, d.h. die fortwährend auftretenden entzündlichen Basisreaktionen im Körper unterdrückt. Dies ist insbesondere auf das Vorhandensein von Linolensäure im Schwarzkümmelöl zurückzuführen. Andererseits werden durch die antioxidativen Wirkung des Arganöls die Zellmembranen stabilisiert, so dass im allgemeinen die Durchlässigkeit der Zellmembranen herabgesetzt wird und so, im speziellen zum Beispiel die Ausschüttung der Mediatorsubstanzen aus der Mastzelle verhindert wird.By the combination according to the invention Thus, on the one hand, the pathogenic immune reactions, i. the ongoing occurring inflammatory Basic reactions in the body suppressed. This is due in particular to the presence of linolenic acid in the black cumin oil. on the other hand The cell membranes become due to the antioxidant effect of argan oil stabilized, so that in general the permeability of the cell membranes and so, in particular, for example, the payout of Mediatorsubstanzen from the mast cell is prevented.
Aufgrund dieser physiologischen Vorgänge kann nun der Zellregenerationsprozess ungehindert einsetzen.by virtue of these physiological processes Now the cell regeneration process can use unhindered.
Dieser durch die erfindungsgemäße Kombination einzigartig hervorgerufene synergistische Effekt ist für das hohe Maß an Zellregeneration bzw. Zellverjüngung verantwortlich.This by the combination according to the invention uniquely created synergistic effect is for the high Measure Cell regeneration or cell rejuvenation responsible.
So verlangsamt Arganöl in Kombination mit Schwarzkümmelöl signifikant den Hautalterungsprozess, mildert Falten und andere Altererscheinungen.So slows down argan oil in combination with black cumin oil significantly the skin aging process, relieves wrinkles and other aging effects.
Die durchblutungsfördernden Wirkung der erfindungsgemäßen Kombination führt ferner zu einer Anti-Cellulite-Wirkung.The promoting blood circulation Effect of the combination according to the invention leads further to an anti-cellulite effect.
Dies gilt sowohl bei der oralen Einnahme z.B. als Nahrungsergänzungsmittel bzw. diätetisches Lebensmittel als auch bei der topischen Applikation.This applies to both oral intake e.g. as a dietary supplement or dietary Food as well as the topical application.
Als Nahrungsergänzungsmittel bzw. diätetisches Lebensmittel liegt die erfindungsgemässe Zusammensetzung bevorzugt in Form von Weichgelatinekapseln vor.When Dietary supplements or dietary Food is the composition of the invention is preferred in the form of soft gelatin capsules.
Das erfindungsgemäße Nahrungsergänzungsmittel kann ferner einen oder mehrere Stoffe; ausgewählt aus Antioxidantien, Carotinoiden, Coenzym Q10, Vitaminen, Mineralstoffen, Spurenelementen und bioaktiven Nähr- und Schutzstoffen aus Pflanzen enthalten. Ferner Aromastoffe, Geschmackskorrigentia, Farbstoffe, Gycerol, Weichhaltemittel essbare ölige Träger und Vitamine.The dietary supplement according to the invention may further comprise one or more substances; selected from antioxidants, carotenoids, coenzyme Q 10 , vitamins, minerals, trace elements and bioactive nutrients and protective substances from plants. In addition, flavorings, Geschmackskorrigentia, dyes, glycerol, softening agents edible oily carriers and vitamins.
Hierbei ist es bevorzugt wenn der essbare ölige Träger ausgewählt ist aus Sanddornöl, süßem Mandelöl, Aprikosenkernöl, Avocadoöl, Sojaöl, Leinsamenöl, Rapsöl, Distelöl (Safloröl), Sonnenblumenöl, Olivenöl, Nussöle, insbesondere Erdnussöl, Baumwollsamenöl, Kokosöl, Palmöl, Fischöl, Nachtkerzenöl, Traubenkernöl, Kürbiskemöl, Weizenkeimöl, Teesamenöl, Maisöl, Haselnussöl, Palmkernöl und Sesamöl.in this connection it is preferable that the edible oily carrier is selected from sea buckthorn oil, sweet almond oil, apricot kernel oil, avocado oil, soybean oil, linseed oil, rapeseed oil, thistle oil (safflower oil), sunflower oil, olive oil, nut oils, in particular Peanut oil, Cottonseed oil, Coconut oil, Palm oil, Fish oil, Evening primrose oil, Grape seed oil, Pumpkin seed oil, wheat germ oil, tea seed oil, corn oil, hazelnut oil, palm kernel oil and sesame oil.
Weiterhin kann das erfindungsgemäße Nahrungsergänzungsmittel bzw.Farther can the dietary supplement according to the invention respectively.
diätetisches Lebensmittel einen oder mehrere Stoffe ausgewählt aus den sekundären Pflanzeninhaltsstoffen, wie z.B. Polyphenole, Saponine, Phytoöstrogene, Phytoandrogene und Flavonoide enthalten.dietetic Food one or more substances selected from the secondary plant ingredients, such as. Polyphenols, saponins, phytoestrogens, phytoandrogens and Flavonoids included.
In
einer bevorzugten Ausführungsform
umfasst das Nahrungsergänzungsmittel
bzw. diätetische
Lebensmittel folgende Inhaltsstoffe:
Arganöl, Schwarzkümmelöl, B-Vitamine, Tocopherole,
Retinol, Carotinoide, Zink, Polyphenole, Molybdän, Kupfer, Mangan, Kieselerde.
Mineralstoffe, Antioxidantien und Spurenelemente.In a preferred embodiment, the dietary supplement or dietetic foods comprise the following ingredients:
Argan oil, black cumin oil, B vitamins, tocopherols, retinol, carotenoids, zinc, polyphenols, molybdenum, copper, manganese, silica. Minerals, antioxidants and trace elements.
Hierbei
ist folgende Zusammensetzung ganz besonders bevorzugt (Mengenangabe
in Gewichts-%):
In einer zweiten Ausführungsform betrifft die vorliegende Erfindung eine Zusammensetzung enthaltend eine Kombination von Schwarzkümmelöl und Arganöl zur topischen Applikation auf die Haut.In a second embodiment The present invention relates to a composition containing a combination of black cumin oil and argan oil for topical Application on the skin.
Die Inhaltsstoffe der erfindungsgemässen Zusammensetzungen können auch in mikroverkapselter Form oder als Liposomen vorliegen.The Ingredients of the inventive Compositions can also in microencapsulated form or as liposomes.
Die Zusammensetzungen können nach dem Fachmann bekannten Techniken unter Verwendung von üblicherweise verwendeten Hilfsstoffen formuliert werden, wie z.B. in „Remington's Pharmaceutical Sciences, 15. Auflage., Mack Publishing Co., New Jersey (1991) beschrieben.The Compositions can according to the skilled person known techniques using usually used adjuncts are formulated, e.g. in "Remington's Pharmaceutical Sciences, 15th Ed., Mack Publishing Co., New Jersey (1991).
Die erfindungsgemässe Zusammensetzung zur topischen Applikation kann zusätzlich zu der Kombination aus Schwarzkümmelöl und Arganöl noch ein oder mehrere Stoffe ausgewählt aus Emulgatoren, Detergentien, Schaumstabilisatoren, Verdickungsmitteln, Feuchthaltemitteln, wässrige Trägern wie z.B. Wasser, Alkohol, Wasser-Alkoholgemische, Glycerin, Glyceri-Wassergemische; ölige Trägern, wie z.B. natürliche Öle, Neutralöle, Mineralöle, Cremegrundlagen, wie z.B. O/W- und W/O-Grundlagen, Vaseline, Wachse, PEG-Glyceride, Permeationsbeschleunigern, Entschäumungsmitteln, Emollient (Weichmacher), Aminosäuren, Puffersubstanzen, Konservierungsmitteln wie zu Beispiel Sodium Benzoate, Phenoxyethanol und Pentylenglycol, Antioxidantien, Aromastoffen, Geruchskorrigentien, Parfüm, Farbstoffen, Fettsäuren, Moisturizern, Hautschutzstoffen, Vitaminen, Lichtschutzfaktoren, α-Hydroxysäuren, organischen Säuren, Fettsäuren, quaternäre Verbindungen, Retinoiden, Metalloxiden, Seidenproteinen, Sacchariden, Zuckeralskoholen, antiinflammatorisch wirkenden Substanzen, Filmbildnern, Antistatika, Enzymen wie zum Beispiel Lipasen, Proteasen, Pankreatin, Ficin, Kollagen sowie Kollagenasen umfassen.The invention Composition for topical application may be in addition to the combination of black cumin oil and argan oil one more or more substances selected from emulsifiers, detergents, foam stabilizers, thickeners, Humectants, aqueous carriers such as. Water, alcohol, water-alcohol mixtures, glycerine, glycerine-water mixtures; oily carriers, like e.g. natural oils, neutral oils, mineral oils, cream bases, such as. O / W and W / O basics, vaseline, waxes, PEG glycerides, Permeation accelerators, defoaming agents, emollients (plasticizers), Amino acids, Buffer substances, preservatives such as, for example, sodium benzoate, Phenoxyethanol and Pentylene Glycol, Antioxidants, Flavorings, Smell Correctives, Perfume, Dyes, fatty acids, Moisturizers, skin protection substances, vitamins, sun protection factors, α-hydroxy acids, organic acids, fatty acids, quaternary compounds, Retinoids, metal oxides, silk proteins, saccharides, sugar alcohols, anti-inflammatory substances, film-forming agents, antistatic agents, Enzymes such as lipases, proteases, pancreatin, ficin, Collagen and collagenases.
Hierbei ist ein Zusammensetzung zur topischen Applikation auf die Haut in Form eines Duschgels, einer Körperlotion, einer Gesichtscreme oder in Form eines Pflegekonzentrates insbesondere zur Pflege der Brust und des Dekolletes bevorzugt.in this connection is a composition for topical application to the skin in Form of a shower gel, a body lotion, a face cream or in the form of a care concentrate in particular for the care of the chest and the décolleté preferred.
Ferner ist die erfindungsgemäße Zusammensetzung zur topischen Applikation auf Haar und Nagel, zum Beispiel in Form eines Haarshampoos, Haarspülung, Haarconditioner, Haarwassers, Haargels, Haarsprays, Haarlacks, Haarfestigers, sowie in Form eines Nagellacks, Nagelöls, geeignet.Furthermore, the composition according to the invention for topical application to hair and nail, For example, in the form of a hair shampoo, hair conditioner, hair conditioner, hair lotions, hair gels, hair sprays, hair dyes, hair fixatives, as well as in the form of a nail polish, nail oil suitable.
In einer bevorzugten Ausführungsform umfasst das erfindungsgemässe Duschgel zusätzlich zu der Kombination aus Schwarzkümmelöl und Arganöl noch ein oder mehrere Stoffe ausgewählt aus Wasser, gegebenenfalls destilliertes Wasser, Natriumlaurylsulfat, Cocamidopropylbetain, Cocamidopropylhydroxysultain, Parfüm, Hexylcinnamaldehyd, Linalool, Limonen, Polyethylenglycol-300-capryl-caprinsäureglyceride, Polyethylenglycol(2000), Sodium Benzoate, Zitronensäure, hydriertes Rizinusöl, 2-Phenoxyethanol, Methyl- Ethyl-, n-Butyl-, iso-Butyl-, Propyl-para-Hydroxybenzoesäureester, Polyquaternium-10, C.I. 19140 und C.I. 16255 sowie Enzymen wie zum Beispiel Lipasen, Proteasen, Pankreatin, Ficin, Kollagen sowie Kollagenasen.In a preferred embodiment includes the inventive Shower gel in addition to the combination of black cumin oil and argan oil one more or more substances selected from water, optionally distilled water, sodium lauryl sulphate, Cocamidopropylbetaine, cocamidopropylhydroxysultaine, perfume, hexylcinnamaldehyde, Linalool, limonene, polyethylene glycol-300-capryl-caprylic acid glycerides, Polyethylene glycol (2000), sodium benzoate, citric acid, hydrogenated Castor oil, 2-phenoxyethanol, methyl-ethyl, n-butyl, iso-butyl, propyl-para-hydroxybenzoic acid ester, Polyquaternium-10, C.I. 19140 and C.I. 16255 as well as enzymes such as For example, lipases, proteases, pancreatin, ficin, collagen and collagenases.
Bevorzugt ist hierbei, wenn das Duschgel die folgenden Inhaltsstoffe umfasst: Schwarzkümmelöl, Arganöl, Wasser, gegebenenfalls destilliertes Wasser, Natriumlaurylsulfat, Cocamidopropylbetain, Cocamidopropylhydroxysultain, Parfüm, Hexylcinnamaldehyd, Linalool, Limonen, Polyethylenglycol-300-caprylcaprinsäureglyceride, Polyethylenglycol(2000), Sodium Benzoate, hydriertes Rizinusöl, 2-Phenoxyethanol, Methyl- Ethyl-, n-Butyl-, iso-Butyl-, Propyl-para-Hydroxybenzoesäureester, Polyquaternium-10, C.I. 19140 und C.I. 16255 sowie Zitronensäure, Enzyme wie zum Beispiel Lipasen, Proteasen, Pankreatin, Ficin, Kollagen sowie Kollagenasen.Prefers is here, if the shower gel includes the following ingredients: Black Cumin Oil, Argan Oil, Water, optionally distilled water, sodium lauryl sulfate, cocamidopropyl betaine, Cocamidopropylhydroxysultaine, perfume, hexylcinnamaldehyde, linalool, Limonene, polyethylene glycol-300-caprylcaprylic acid glycerides, polyethylene glycol (2000), Sodium benzoate, hydrogenated castor oil, 2-phenoxyethanol, methyl ethyl, n-butyl, iso-butyl, propyl-para-hydroxybenzoic acid ester, Polyquaternium-10, C.I. 19140 and C.I. 16255 as well as citric acid, enzymes such as Lipases, proteases, pancreatin, ficin, collagen and collagenases.
Ganz
besonders bevorzugt umfasst das Duschgel die folgende Zusammensetzung
(Mengenangabe in Gewichts-%):
In einer bevorzugten Ausführungsform umfasst die Körperlotion zusätzlich zu der Kombination aus Schwarzkümmelöl und Arganöl noch ein oder mehrere Stoffe ausgewählt aus Wasser, gegebenenfalls destilliertem Wasser, Polyacrylamid/C13-14 iso-Paraffin/Laureth 7, Propylenglycol, Aloe Vera Gel, Diethylhexylcarbonat, Jojobaöl, Olea Europea (Olivenöl), Tocopherolacetat, Saccharidisomerat, Parfüm, Hexylcinnamaldehyd, Linalool, Limonen, Benzylsalicylat, Hydroxyisohexyl-3-cylohexencarboxaldehyd, Citronellol, Citral, Coumarin, süßes Mandelöl, Phenoxyethanol; Methyldibromglutaronitril und Zitronensäure.In a preferred embodiment, in addition to the combination of black cumin oil and argan oil, the body lotion further comprises one or more of water, optionally distilled water, polyacrylamide / C 13-14 iso-paraffin / laureth 7, propylene glycol, aloe vera gel, diethylhexyl carbonate, jojoba oil , Olea Europea (olive oil), tocopherol acetate, saccharide isomerate, perfume, hexylcinnamaldehyde, linalool, limonene, benzyl salicylate, hydroxyisohexyl-3-cyclohexene carboxaldehyde, citronellol, citral, coumarin, sweet almond oil, phenoxyethanol; Methyl dibromoglutaronitrile and citric acid.
Bevorzugt ist es hierbei, wenn das Körperlotion die folgenden Inhaltsstoffe umfasst: Schwarzkümmelöl, Arganöl, Wasser, gegebenenfalls destilliertes Wasser, Polyacrylamid/C13-14 iso-Paraffin/Laureth 7, Propylenglycol, Aloe Vera Gel, Diethylhexylcarbonat, Jojobaöl, Olea Europea (Olivenöl), Tocopherolacetate, Saccharidisomerat, Parfüm, Hexylcinnamaldehyd, Linalool, Limonen, Benzylsalicylat, Hydroxyisohexyl-3-cylohexencarboxaldehyd, Citronellol, Citral, Coumarin, süßes Mandelöl, Phenoxyethanol; Methyldibromglutaronitril und Zitronensäure, Enzyme wie zum Beispiel Lipasen, Proteasen, Pankreatin, Ficin, Kollagen sowie Kollagenasen.Here, it is preferred if the body lotion comprises the following ingredients: black cumin oil, argan oil, water, optionally distilled water, polyacrylamide / C 13-14 iso-paraffin / laureth 7, propylene glycol, aloe vera gel, diethylhexyl carbonate, jojoba oil, Olea Europea (olive oil ), Tocopherol acetates, saccharide isomerate, perfume, hexylcinnamaldehyde, linalool, limonene, benzyl salicylate, hydroxyisohexyl-3-cyclohexene carboxaldehyde, citronellol, citral, coumarin, sweet almond oil, phenoxyethanol; Methyldibromoglutaronitrile and citric acid, enzymes such as lipases, proteases, pancreatin, ficin, collagen and collagenases.
In
einer ganz besonders bevorzugten Ausführungsform umfasst die Körperlotion
die folgende Zusammensetzung (Mengenangabe in Gewichts-%):
In einer bevorzugten Ausführungsform umfasst die erfindungsgemässe Pflegecreme zusätzlich zu der Kombination aus Schwarzkümmelöl und Arganöl noch ein oder mehrere Stoffe ausgewählt aus Wasser, gegebenenfalls destilliertes Wasser, Cyclohexasiloxane, Cyclopentasiloxane, Isohexadecan, Saccharidisomerat, Propylenglycol, hydrolisiertes Sericin, Bis-PEG/PPG-14/14 Dimethicon Natriumchlorid, Cetyl PEG/PPG-10/1 Dimethicon, Cetydimethicon, Natriumlactat, Natrium PCA (Natrium pyroglutamat), Glycin, Fructose, Harnstoff, Niacinamid, Vitamin A (Retinol), Ceramide III, Phytoshingisine, Inositol, Natriumbenzoat, Lactic acid, Tocopherol, hydriertes Rizinusöl, Jojobaöl, weißes Bienenwachs, Ceramide III, Phenoxyethanol, Methyldibromglutaronitril, Phytoshingosine, Parfüm, Hexylcinnaldehyd, Linalool, Limonen, Benzylsalicylat, Hydroxy-iso-hexyl-13-cyclohexencarboxaldehyd, Butylphenylmethylpropional, Citronellol, Zitronensäure, Vitamine Fructose, Lecithin sowie Enzyme wie zum Beispiel Lipasen, Proteasen, Pankreatin, Ficin, Kollagen sowie Kollagenasen.In a preferred embodiment includes the inventive Care cream in addition to the combination of black cumin oil and argan oil one more or more substances selected from water, optionally distilled water, cyclohexasiloxanes, Cyclopentasiloxanes, isohexadecane, saccharide isomerate, propylene glycol, hydrolyzed sericin, bis-PEG / PPG-14/14 dimethicone sodium chloride, Cetyl PEG / PPG-10/1 dimethicone, cetydimethicone, sodium lactate, sodium PCA (sodium pyroglutamate), glycine, fructose, urea, niacinamide, Vitamin A (retinol), ceramides III, phytoshingisins, inositol, sodium benzoate, Lactic acid, tocopherol, hydrogenated castor oil, jojoba oil, white beeswax, ceramides III, Phenoxyethanol, Methyldibromoglutaronitrile, Phytoshingosine, Perfume, Hexylcinnaldehyde, Linalool, limonene, benzyl salicylate, hydroxy-iso-hexyl-13-cyclohexene carboxaldehyde, Butylphenylmethylpropional, citronellol, citric acid, vitamins Fructose, lecithin and enzymes such as lipases, proteases, Pancreatin, ficin, collagen and collagenases.
Bevorzugt umfasst die Pflegecreme: Schwarzkümmelöl, Arganöl, Wasser, gegebenenfalls destilliertes Wasser, Cyclohexasiloxane, Cyclopentasiloxane, Isohexadecan, Saccharidisomerat, Propylenglycol, hydrolisiertes SeriCin, Bis-PEG/PPG-14/14 Dimethicon Natrium Chlorid, Cetyl PEG/PPG-10/1 Dimethicon, Cetydimethicon, Natriumlactal, Natrium PCA, Glycin, Fructose, Harnstoff, Niacinamid, Inositol, Natriumbenzoat, Lictic Acid, Tocopherol, hydriertes Rizinusöl, Jojobaöl, weißes Bienenwachs, Ceramide III, Palmitoylpentapeptide-III, Phenoxyethanol, Methyldibromglutaronitril, Phytoshingosine, Parfüm, Hexylcinnaldehyd, Linalool, Limonen, Benzylsalicylat, Hydroxy-iso-hexyl-13-cyclohexencarboxaldehyd, Butylphenylmethylpropional, Citronellol, Vitamine, Lecithin und Zitronensäure sowie Enzyme wie zum Beispiel Lipasen, Proteasen, Pankreatin, Ficin, Kollagen sowie Kollagenasen.Prefers includes the care cream: black cumin oil, argan oil, water, optionally distilled water, Cyclohexasiloxanes, cyclopentasiloxanes, isohexadecane, saccharide isomerate, Propylene glycol, hydrolyzed SeriCin, bis-PEG / PPG-14/14 dimethicone sodium chloride, Cetyl PEG / PPG-10/1 dimethicone, cetydimethicone, sodium lactal, sodium PCA, glycine, fructose, urea, niacinamide, inositol, sodium benzoate, Lictic acid, tocopherol, hydrogenated castor oil, jojoba oil, white beeswax, ceramides III, Palmitoyl pentapeptide-III, phenoxyethanol, Methyldibromoglutaronitrile, phytoshingosine, perfume, hexylcinnaldehyde, linalool, Limonene, benzyl salicylate, hydroxy-iso-hexyl-13-cyclohexenecarboxaldehyde, butylphenylmethylpropional, Citronellol, vitamins, lecithin and citric acid as well as enzymes such as Lipases, proteases, pancreatin, ficin, collagen and collagenases.
Ganz
besonders bevorzugt umfasst die Pflegecreme die folgende Zusammensetzung
(Mengenangabe in Gewichts-%):
Im Fall des Pflegekonzentrates ist es weiterhin bevorzugt, wenn das Konzentrat in Einzeldosen insbesondere Form von Perlen/Weichgelatinekapseln zur topischen Applikation vorliegt.in the Case of the care concentrate, it is further preferred if the Concentrate in single doses, especially in the form of beads / soft gelatine capsules for topical application.
Bevorzugt umfasst das Pflegekonzentrat zusätzlich zu der Kombination aus Schwarzkümmelöl und Arganöl noch ein oder mehrere Stoffe ausgewählt aus Diethylhexylcarbonat, Retinylpalmitat, Tocopherole, Panthenolderivate, Vitamine, Parfüm, Hexylcinnamaldehyd, Linalool, Limonen, Benzylsalicylat, Hydroxyisohexyl-3-cyclohexencarboxaldehyd, Butylphenylmethylpropional, Citronellol, Ascorbylpalmityl, Lecithin, Glycerylstearat, Glyceryloleat, Zitronensäure, Vitamine, durchblutungsfördernde Öle wie zum Beispiel Rosenöl und Rosmarienöl, beruhigende Öle wie zum Beispiel Melissenöl, Lecithin sowie Enzyme wie zum Beispiel Lipasen, Proteasen, Pankreatin, Ficin, Kollagen sowie Kollagenasen.Prefers includes the care concentrate additionally to the combination of black cumin oil and argan oil one more or more substances selected from diethylhexyl carbonate, retinyl palmitate, tocopherols, panthenol derivatives, Vitamins, perfume, Hexylcinnamaldehyde, linalool, limonene, benzyl salicylate, hydroxyisohexyl-3-cyclohexenecarboxaldehyde, Butylphenylmethylpropional, citronellol, ascorbylpalmityl, lecithin, Glyceryl stearate, glyceryl oleate, citric acid, vitamins, circulation-promoting oils such as Example rose oil and rosemary oil, soothing oils like lemon balm oil, Lecithin and enzymes such as lipases, proteases, pancreatin, Ficin, collagen and collagenases.
In einer bevorzugten Ausführungsform umfasst das Pflegekonzentrat die folgenden Inhaltsstoffe: Schwarzkümmelöl, Arganöl, Diethylhexylcarbonat, Retinylpalmitat, Tocopherol, Panthenolderivate, Parfüm, Hexylcinnamaldehyd, Linalool, Limonen, Benzylsalicylat, Hydroxyisohexyl-3-cyclohexencarboxaldehyd, Butylphenylmethylpropional, Citronellol, Ascorbylpalmityl, Lecithin, Glycerylstearat, Glyceryloleat, Zitronensäure, Vitamine, sowie Enzyme wie zum Beispiel Lipasen, Proteasen, Pankreatin, Ficin, Kollagen sowie Kollagenasen.In a preferred embodiment The care concentrate contains the following ingredients: black cumin oil, argan oil, diethylhexyl carbonate, Retinyl palmitate, tocopherol, panthenol derivatives, perfume, hexyl cinnamaldehyde, Linalool, limonene, benzyl salicylate, hydroxyisohexyl-3-cyclohexene carboxaldehyde, Butylphenylmethylpropional, citronellol, ascorbylpalmityl, lecithin, Glyceryl stearate, glyceryl oleate, citric acid, vitamins, as well as enzymes such as lipases, proteases, pancreatin, ficin, collagen as well as collagenases.
Ganz
besonders bevorzugt umfasst das Pflegekonzentrat die folgende Zusammensetzung
(Mengenangabe in Gewichts-%):
Claims (24)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE200520007603 DE202005007603U1 (en) | 2005-05-13 | 2005-05-13 | Composition for oral or topical administration, e.g. as a dietary supplement or dietetic food, shower gel, body lotion, cream or care concentrate, comprises argan oil and nigella oil |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE200520007603 DE202005007603U1 (en) | 2005-05-13 | 2005-05-13 | Composition for oral or topical administration, e.g. as a dietary supplement or dietetic food, shower gel, body lotion, cream or care concentrate, comprises argan oil and nigella oil |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE202005007603U1 true DE202005007603U1 (en) | 2005-08-04 |
Family
ID=34833428
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE200520007603 Expired - Lifetime DE202005007603U1 (en) | 2005-05-13 | 2005-05-13 | Composition for oral or topical administration, e.g. as a dietary supplement or dietetic food, shower gel, body lotion, cream or care concentrate, comprises argan oil and nigella oil |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE202005007603U1 (en) |
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1764085A1 (en) * | 2005-09-15 | 2007-03-21 | Aouida, Amin | Cosmetic composition comprising argan oil |
| EP1958614A1 (en) * | 2007-02-14 | 2008-08-20 | Philippe Alleon | Composition containing argan oil and a product based on a plant from the Aloe genus, and cosmetic use thereof |
| FR2926441A1 (en) * | 2008-01-23 | 2009-07-24 | Pascale Ertus | Integration of the argan oil in food preparations, which is useful e.g. as seasoning on green salads or compounds and to reduce cholesterol level, comprises adding argan oil extracted from kernels of the argan tree, to the food |
| WO2010026009A1 (en) * | 2008-09-06 | 2010-03-11 | Henkel Ag & Co. Kgaa | Hair treatment means |
| ITPS20090009A1 (en) * | 2009-04-28 | 2010-10-28 | S C D Smile Di Sanchini Eva | COSMETIC FORMULATION FOR THE TREATMENT AND CARE OF THE SKIN AND PROCEDURE FOR ITS PREPARATION |
| WO2011009862A1 (en) * | 2009-07-21 | 2011-01-27 | Dsm Ip Assets B.V. | Nigella extracts for the treatment of symptoms connected to impaired or imbalanced neurotransmission |
| ITPD20100130A1 (en) * | 2010-04-28 | 2011-10-29 | Antonio Gambino | ANTI-HYPER-HOLESTEROLEMIC PRODUCT |
| US20120093949A1 (en) * | 2010-10-13 | 2012-04-19 | Ilene Steinberg | Systems and methods for treating lice |
| JP2012523396A (en) * | 2009-04-10 | 2012-10-04 | クッタニィ，スレイマン エル | Plant-based composition for the treatment and prevention of viral blood diseases caused by viruses such as human immunodeficiency virus (HIV) or hepatitis C virus |
| WO2011124560A3 (en) * | 2010-04-09 | 2012-10-11 | Dsm Ip Assets B.V. | Hair care compositions |
| WO2014179305A1 (en) * | 2013-04-29 | 2014-11-06 | IINN, Inc. | Soap composition |
| EP3482764A1 (en) | 2017-11-09 | 2019-05-15 | Anton Hübner GmbH & Co. KG | Insect and/or spider repellent comprising black cumin oil |
| US20220087953A1 (en) * | 2019-01-28 | 2022-03-24 | N.S. Oils Ltd. | Compositions comprising thymoquinone and additional biologically active compounds |
-
2005
- 2005-05-13 DE DE200520007603 patent/DE202005007603U1/en not_active Expired - Lifetime
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1764085A1 (en) * | 2005-09-15 | 2007-03-21 | Aouida, Amin | Cosmetic composition comprising argan oil |
| EP1958614A1 (en) * | 2007-02-14 | 2008-08-20 | Philippe Alleon | Composition containing argan oil and a product based on a plant from the Aloe genus, and cosmetic use thereof |
| FR2926441A1 (en) * | 2008-01-23 | 2009-07-24 | Pascale Ertus | Integration of the argan oil in food preparations, which is useful e.g. as seasoning on green salads or compounds and to reduce cholesterol level, comprises adding argan oil extracted from kernels of the argan tree, to the food |
| WO2010026009A1 (en) * | 2008-09-06 | 2010-03-11 | Henkel Ag & Co. Kgaa | Hair treatment means |
| JP2012523396A (en) * | 2009-04-10 | 2012-10-04 | クッタニィ，スレイマン エル | Plant-based composition for the treatment and prevention of viral blood diseases caused by viruses such as human immunodeficiency virus (HIV) or hepatitis C virus |
| ITPS20090009A1 (en) * | 2009-04-28 | 2010-10-28 | S C D Smile Di Sanchini Eva | COSMETIC FORMULATION FOR THE TREATMENT AND CARE OF THE SKIN AND PROCEDURE FOR ITS PREPARATION |
| WO2011009862A1 (en) * | 2009-07-21 | 2011-01-27 | Dsm Ip Assets B.V. | Nigella extracts for the treatment of symptoms connected to impaired or imbalanced neurotransmission |
| WO2011124560A3 (en) * | 2010-04-09 | 2012-10-11 | Dsm Ip Assets B.V. | Hair care compositions |
| ITPD20100130A1 (en) * | 2010-04-28 | 2011-10-29 | Antonio Gambino | ANTI-HYPER-HOLESTEROLEMIC PRODUCT |
| US20120093949A1 (en) * | 2010-10-13 | 2012-04-19 | Ilene Steinberg | Systems and methods for treating lice |
| WO2014179305A1 (en) * | 2013-04-29 | 2014-11-06 | IINN, Inc. | Soap composition |
| EP3482764A1 (en) | 2017-11-09 | 2019-05-15 | Anton Hübner GmbH & Co. KG | Insect and/or spider repellent comprising black cumin oil |
| US20220087953A1 (en) * | 2019-01-28 | 2022-03-24 | N.S. Oils Ltd. | Compositions comprising thymoquinone and additional biologically active compounds |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11571373B2 (en) | Skin care preparations for babies | |
| JP4861606B2 (en) | Topical pharmaceutical composition comprising proanthocyanidins for treating dermatitis | |
| CN106580798B (en) | Full-effect eye cream and preparation method thereof | |
| US7883726B2 (en) | Skin care compositions with botanic seed oils | |
| KR101987903B1 (en) | Cosmetic composition for treating atopic dermatitis and method thereof | |
| JP2010132629A (en) | External composition for skin | |
| US9427394B2 (en) | Hair loss prevention and restoration solution | |
| DE202005007603U1 (en) | Composition for oral or topical administration, e.g. as a dietary supplement or dietetic food, shower gel, body lotion, cream or care concentrate, comprises argan oil and nigella oil | |
| KR102220534B1 (en) | Soothing cream and manufacturing method for the same | |
| DE10033717A1 (en) | Cosmetic and dermatological preparation for removing sebum | |
| KR20160120355A (en) | Skin-brightening cosmetic composition | |
| JP6175280B2 (en) | Composition for improving pores | |
| KR101817514B1 (en) | New use of hesperetin | |
| Khanal et al. | Vegetable oils-based cosmetics | |
| DE202006019183U1 (en) | Sea Buckthorn Skin Care Oil | |
| IL277913B2 (en) | Preparations containing strontium and methylsulfonylmethane (MSM) and their uses in treatment methods | |
| KR102801893B1 (en) | Composition for treating acne containing nanoized bee pollen extract as an active ingredient | |
| EP2192956B1 (en) | Cosmetic or dermatological composition for topical application | |
| KR20150050981A (en) | Cosmetic composition and external composition comprising steroidal lactones for anti-inflammatory | |
| DE202006019184U1 (en) | Moisturizing sea buckthorn skin care gel | |
| KR100638053B1 (en) | Cosmetic composition for alleviating skin irritation containing Soru-Jin extract as an active ingredient | |
| JP4934280B2 (en) | Wrinkle improving agent | |
| JPH11322628A (en) | External preparation for skin | |
| da Costa Sanches et al. | The use of vegetable oils to prevent skin aging | |
| JP4359197B2 (en) | Wrinkle improving agent and skin cosmetic |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R207 | Utility model specification |
Effective date: 20050908 |
|
| R150 | Utility model maintained after payment of first maintenance fee after three years |
Effective date: 20080415 |
|
| R081 | Change of applicant/patentee |
Owner name: HOLZNER, MONIKA A., DE Free format text: FORMER OWNER: HD HEALTH DEVELOPMENT GMBH, 81675 MUENCHEN, DE Effective date: 20090914 |
|
| R151 | Utility model maintained after payment of second maintenance fee after six years | ||
| R151 | Utility model maintained after payment of second maintenance fee after six years |
Effective date: 20110805 |
|
| R158 | Lapse of ip right after 8 years |
Effective date: 20131203 |